Fighting Blindness with 3D-NET "Drug Discovery & Development of Novel Eye Therapeutics"
Poster Feb 17, 2015
Pilar Ventosa-Andrés, Nils Ohnesorge, Yolanda Fernández, Yolanda Alvarez and Breandán Kennedy
Age-related macular degeneration (AMD), diabetic retinopathy (DR), and corneal inflammation are significant causes of irreversible blindness with increasing prevalence as the EU population ages and the “diabetes epidemic” expands. There is an unmet clinical need for more effective treatments to halt or reverse these diseases.
PAIN (vascular Permeability, Angiogenesis, Inflammation and Neurodegeneration) are pathological hallmarks of eye diseases that culminate in blindness. The discovery and development of safe and efficacious drugs modulating these processes will significantly improve the quality of life of patients with these diseases, will reduce the associated economic burden, and enhance pharmaceutical R&D in Europe.
The main researcher objectives of 3D-NET  are:
1. Discovery and development of drugs that target ocular pathologies, namely: retinal vascular permeability, unwanted blood vessel growth, inflammation and cell degeneration.
2. The 3D-NET consortium encompasses the capabilities and infrastructure required to test these drugs in relevant pre-clinical models of ocular disease
This project is funded through a Marie Curie Industry-Academia Pathways and Partnerships grant (IAPP) award from the EU Seventh Framework Programme (EU FP7 2013 - 612218/3D-NET). IAPP actions are based on the transfer of Knowledge and Technology between Industry and Academia.
New Biotransformation Prediction Engine Integrated into a Metabolite Identification SolutionPoster
Here we present a new prediction algorithm that determines the likelihood of biotransformation reactions, and subsequent metabolite identification, within an automated processing routine.READ MORE
A New Method for Analyzing MSe/All Ions Fragmentation in Xenobiotic Metabolism StudiesPoster
During early drug discovery, the study of metabolism plays an essential role in determining which drug candidates move forward into development and later stages. As an alternative to traditional Data Dependent Acquisition (DDA), the use of MSE/All Ions Fragmentation (AIF) has become common in metabolite identification workflows for the analysis of metabolic hot spots. Here we present a solution for analysis of MSE/AlF in metID studies.READ MORE
Extracorporeal shockwave therapy accelerates motor axon regeneration despite a phenotypically mismatched environmentPoster
A femoral nerve defect model was adapted for the evaluation of proregenerative effects of extracorporeal shockwave therapy (ESWT). Functional evaluation, histology and qRT-PCR data show differences between sensory and motor-derived nerve transplants and a pro-regenerative effect of ESWT. These data provide evidence for the clinical application of ESWT after autologous nerve transplantation as a novel non-invasive method.READ MORE